Crispr Therapeutics Stock Been: A Roller-Coaster Year Unpacked
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Selecting a total market ETF for a Roth IRA involves evaluating expense ratios and tracking performance. This guide outlines practical criteria.
28,330 articlesCRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
A veteran CIO warns that even stellar AI earnings may not keep momentum, suggesting the market is testing whether thi...
SK Hynix moves to list in the U.S., challenging Micron for memory-chip dominance as AI-driven demand and cyclical dyn...
Crypto markets stay volatile and 24/7 in 2026, pushing funded trading models to the fore. This report profiles the to...
AI-driven tools are accelerating in mortgage lending and brokerage work, raising the bar for service. The industry ag...
Oil weakness and a tech-led stock rally push the VIX toward the 17 level as traders return to equities.
Solana stands at a turning point as SOL tests a key price band. Traders are watching resistance near the $100 mark an...
AI-driven optimism pushes the S&P 500 to an eighth consecutive week of gains, led by big tech earnings and AI infrast...
Kris Zacuto has joined Christie’s International Real Estate Southern California as director of luxury estates, bringi...
A leading technology analyst questions Intel's current stock value, arguing the market is pricing an AI cycle far int...
XBTFX announced the MCP Server and Skills Hub on July 1, 2026, creating a bridge between automated software and live ...
Oil rises and stock indexes slip as tensions in the Strait of Hormuz intensify. Investors watch the ships dark clock ...